1,922 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
1,869 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
205 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
6,818 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
15,600 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
512 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
255,752 followers
RT @CD_AACR: If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Scree…
19,802 followers
If you're at the #AACR23, Meet-the-Expert session with @KStegmaier_DFCI, don't miss her recent paper— An in vivo #CRISPR Screening Platform for Prioritizing Therapeutic Targets in Acute Myeloid #Leukemia. https://t.co/6UD0fEmKe5 https://t.co/DchICXZBYg
19,802 followers
RT @DrBaileeSliker: Attend @KStegmaier_DFCI's talk today during the #AACR22 Advances in Organ Site Research-Pediatric Cancer session and wa…
24 followers
255,752 followers
3,918 followers
5,120 followers
1,922 followers
Attend @KStegmaier_DFCI's talk today during the #AACR22 Advances in Organ Site Research-Pediatric Cancer session and want more from her lab? Then check out this @CD_AACR paper! https://t.co/bVHfdaHGw3
4,095 followers
2,499 followers
1,922 followers
19,802 followers
Check out the Cancer Discovery paper by one of #AACR22 speakers, An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia. https://t.co/aYJ3iBUKfF @KStegmaier_DFCI @DanaFarber @broadinstitute #leusm https://t.co
19,802 followers
RT @NCICancerBio: Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al…
97 followers
RT @KStegmaier_DFCI: Thank you @theNCI for your support and ongoing interest in our work
313 followers
RT @KStegmaier_DFCI: Thank you @theNCI for your support and ongoing interest in our work
834 followers
RT @KStegmaier_DFCI: Thank you @theNCI for your support and ongoing interest in our work
161 followers
RT @NCICancerBio: Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al…
1,215 followers
Thank you @theNCI for your support and ongoing interest in our work
2,280 followers
RT @NCICancerBio: Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al…
269 followers
RT @NCICancerBio: Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al…
15,600 followers
RT @NCICancerBio: Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al…
249 followers
RT @NCICancerBio: Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al…
6,052 followers
Using a #CRISPR screening approach and experimental models in an @theNCI funded study, @KStegmaier_DFCI @DanaFarber et al. identified SLC5A3 as a metabolic vulnerability and MARCH5 as a critical apoptosis regulator in #AcuteMyeloidLeukemia (#AML) @CD_AACR
67 followers
RT @CD_AACR: From the February issue: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
4 followers
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML https://t.co/zU1NsttOXu
8,949 followers
RT @CD_AACR: From the February issue: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
1,215 followers
RT @CD_AACR: From the February issue: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
2,499 followers
RT @CD_AACR: From the February issue: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
15,600 followers
RT @CD_AACR: From the February issue: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
19,802 followers
From the February issue: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia by Lin, Stegmaier et al. https://t.co/5MOGh6vYit @KStegmaier_DFCI @DanaFarber @broadinstitute #leusm https://t.co/SyDdDUYd4o
1,869 followers
RT @ElizSMcKenna: ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
19,802 followers
RT @ElizSMcKenna: ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
24 followers
RT @ElizSMcKenna: ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
834 followers
RT @ElizSMcKenna: ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
29 followers
RT @ElizSMcKenna: ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
2,499 followers
RT @ElizSMcKenna: ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia…
15,600 followers
ICYMI in @CD_AACR: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @DanaFarber @broadinstitute #leusm #ASH21 https://t.co/PgeHthqKif
4,350 followers
الجينين SLC5A3 و MARCH5 قد يشكلان أهدافاً محتملة لعلاج ابيضاض الدم النقوي الحاد عند الأطفال https://t.co/9tSKnC9gRT
1,346 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
346 followers
Congratulations to Dr. Shan Lin and many contributors from @KStegmaier_DFCI, @broadinstitute, and beyond on a fascinating study providing guidance on how to prioritize and validate targets identified in genomic screens
925 followers
New article: An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML https://t.co/BkVlZiLH1f #AML #leusm #hematology https://t.co/yul56ICUku
7,333 followers
843 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
1,558 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
843 followers
RT @CD_AACR: #OnlineFirst: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid leukemia. https://t.…
15,600 followers
RT @CD_AACR: #OnlineFirst: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid leukemia. https://t.…
6,365 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
8,949 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
19,802 followers
#OnlineFirst: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid leukemia. https://t.co/qAqIQw24Eu. @KStegmaier_DFCI @DanaFarber @broadinstitute. #leusm https://t.co/lHR5VYzFRT
1,725 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
3,221 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
2,755 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
8,018 followers
'We have established a CRISPR screening approach using orthotopic xenograft models to validate and prioritize AML-enriched dependencies in vivo, including in CRISPR-competent AML PDX models tractable for genome editing' https://t.co/bgrCx7huQT
1,369 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
19,802 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
19,802 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
15,600 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
323 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
69 followers
RT @KStegmaier_DFCI: Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic target…
1,215 followers
Out today in @CD_AACR from postdoc Shan Lin. "An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML." Congratulations Shan! @DFBC_PedCare
323 followers
RT @ElizSMcKenna: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @D…
15,600 followers
An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia @KStegmaier_DFCI @DanaFarber @broadinstitute #leusm https://t.co/PgeHthqKif